These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunological's host profile for HPV and Chlamydia trachomatis, a cervical cancer cofactor. Simonetti AC; Melo JH; de Souza PR; Bruneska D; de Lima Filho JL Microbes Infect; 2009 Apr; 11(4):435-42. PubMed ID: 19397882 [TBL] [Abstract][Full Text] [Related]
3. Insights into the Role of Innate Immunity in Cervicovaginal Papillomavirus Infection from Studies Using Gene-Deficient Mice. Scagnolari C; Cannella F; Pierangeli A; Mellinger Pilgrim R; Antonelli G; Rowley D; Wong M; Best S; Xing D; Roden RBS; Viscidi R J Virol; 2020 Jun; 94(12):. PubMed ID: 32295905 [TBL] [Abstract][Full Text] [Related]
4. Characterization of the Growth of Nogueira AT; Braun KM; Carabeo RA Front Cell Infect Microbiol; 2017; 7():438. PubMed ID: 29067282 [No Abstract] [Full Text] [Related]
5. Design of a multi-epitope protein vaccine against herpes simplex virus, human papillomavirus and Chlamydia trachomatis as the main causes of sexually transmitted diseases. Dorosti H; Eskandari S; Zarei M; Nezafat N; Ghasemi Y Infect Genet Evol; 2021 Dec; 96():105136. PubMed ID: 34775078 [TBL] [Abstract][Full Text] [Related]
7. Chlamydia trachomatis and human papillomavirus infection in Indian women with sexually transmitted diseases and cervical precancerous and cancerous lesions. Gopalkrishna V; Aggarwal N; Malhotra VL; Koranne RV; Mohan VP; Mittal A; Das BC Clin Microbiol Infect; 2000 Feb; 6(2):88-93. PubMed ID: 11168078 [TBL] [Abstract][Full Text] [Related]